Sfoglia per Autore CAGNOTTA, CECILIA
Mostrati risultati da 1 a 6 di 6
The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database
2023 Liguori, V.; Gaio, M.; Zinzi, A.; Cagnotta, C.; Riccardi, C.; Docimo, G.; Capuano, A.
Can Pharmacovigilance Data Represent a Potential Tool for Early Detection of the Antibiotic Resistance Phenomenon?
2024 Cagnotta, C.; Zinzi, A.; Gargano, F.; Liguori, V.; Campitiello, M. R.; Perrella, A.; Capuano, A.; Rafaniello, C.; Trama, U.
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination
2025 Fraenza, Federica; Cagnotta, Cecilia; Gaio, Mario; Sportiello, Liberata; Scavone, Cristina; Capuano, Annalisa; Trama, Ugo
Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 monoclonal antibodies: a systematic review and meta-analysis of observational studies.
2025 Scavone, C; Cagnotta, C; Sportiello, L; Maniscalco, Gt; Ragone, A; Frasca, M; Rinaldi, B; Capuano, A.
A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use
2025 Zinzi, A.; Gaio, M.; Ruggiero, D.; Riccardi, C.; Cagnotta, C.; Pentella, C.; Capuano, A.; Rafaniello, C.
Parental vaccine hesitancy: Recent evidences support the need to implement targeted communication strategies
2025 Cagnotta, C.; Lettera, N.; Cardillo, M.; Pirozzi, D.; Catalan-Matamoros, D.; Capuano, A.; Scavone, C.
Mostrati risultati da 1 a 6 di 6
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile